Current Lab Members
Mukesh Tandi
Ph.D. Scholar
Email: p20190408@pilani.bits-pilani.ac.in
Joining: January 2020
MS (Pharm.) Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli (U.P.).
My current research focuses on the development of small-molecule inhibitors targeting various essential enzymes and proteins in Mycobacterium tuberculosis for the treatment of Tuberculosis (TB). Concurrently, I am leading efforts in the design and synthesis of novel amphiphilic polymers tailored as drug nanocarriers.
Shailesh Mani Tripathi
Ph.D. Scholar
Email: p20210053@pilani.bits-pilani.ac.in
Joining: September 2021
M.Pharm. Pharmaceutical Chemistry, Central University of Rajasthan
My research revolves around utilizing cutting-edge techniques such as large-scale molecular docking and enhanced molecular dynamics simulations to pinpoint new inhibitors for anticancer targets. In addition I am translating promising virtual hits into tangible molecules through organic synthesis for further biological screening.
Mukul Kore
Ph.D. Scholar
mukul.kore@pilani.bits-pilani.ac.in
Joined Department of Pharmacy BITS Pilani on March 2022
MS (Pharm.) Medicinal Chemistry, NIPER Mohali, (Punjab)
My research focus encompasses the development of novel therapeutic interventions for infectious diseases, particularly malaria and tuberculosis. Presently, I am engaged in the strategic design of hybrid compounds tailored to target malaria-causing Plasmodium parasites. This endeavor is specifically geared towards addressing the challenge posed by resistant strains of Plasmodium.
Harsha Valluri
Ph.D. Scholar
Email: p20200309@pilani.bits-pilani.ac.in
Joining: September 2022
M.Pharm. Pharmaceutical Chemistry, BITS Pilani, Pilani Campus
My research interest lies in understanding the anticancer mechanism of the newly developed hybrid molecules in Dr. Sundriyal's lab using various biological techniques.
Animesh Majumdar
Ph.D. Scholar
Email: p20220054@pilani.bits-pilani.ac.in
Joining: September 2022
M.Pharm Pharmaceutical Chemistry from JAMIA HAMDARD, New Delhi.
My research focuses on developing quinazoline-based inhibitors to treat Malaria. It combines computational methods like Homology Modeling, Virtual Screening, and MD Simulation with wet lab synthesis using advanced organic chemistry. Through this multidisciplinary approach, I aim to create effective anti-malarial compounds to combat malaria.
Samir Tikaram Sahu
JRF CDRF-BITS Pilani
Email ID: samirsahu520@gmail.com
MS (Pharm.) Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli (U.P.).
Currently, I'm involved in the development of zeolite-encapsulated small-molecule epigenetic modulators to combat cancer and drug resistance. This approach integrates synthetic chemistry, computational modeling, and innovative encapsulation techniques for enhanced efficacy and controlled release.
Atharva Rajesh Chavan
M.Pharm (Pharmaceutical Chemistry)
Email: h20220302@pilani.bits-pilani.ac.in
Joining: August 2022
My research aims to synthesize new polymers and improve the chemical modification of natural polymers. This interdisciplinary approach combines materials science and synthetic chemistry to engineer customized polymeric architectures for various biomedical applications.